Welcome to Scop3P

Search for the desired protein with Uniprot accession, protein name/keyword, ProteomeXchange ID or PDB id

  • Zoom in and zoom out (both with mouse and buttons on the right top corner) to see modificationson the protein
  • Slide the chart to see other modifications (both with mouse and buttons on the right topcorner)
  • Hover on the modification to see more information and position on the structure.
PDB 
 AlphaFold
Phospho-sites

Showing 16 results

Swiss-Prot Position Modification Source Evidence Singly phosphorylated
131 TYR UP Combined
263 SER UP Similarity
453 THR PRIDE yes
455 SER UP, PRIDE Combined yes
457 SER PRIDE
459 SER UP, PRIDE Combined yes
481 SER UP, PRIDE Combined yes
484 SER PRIDE yes
579 TYR PRIDE yes
639 THR UP Combined
663 SER UP, PRIDE Combined yes
667 SER PRIDE yes
682 TYR UP, PRIDE Combined yes
839 SER UP, PRIDE Combined yes
1066 SER PRIDE yes
1073 TYR PRIDE yes

3D structure is not available

Display Settings

Hover over to see the values, zoom (in/out) or drag by using the mouse pointer.

Phosphorylated amino acids are colored red on the inner ring.

The first amino acid of the protein sequence is colored darker on each ring.

Phospho peptides

Showing 21 results

Sequence Modified position (Swiss-Prot) Peptide start Peptide end Modified position (Peptide) Number of projects
453 453 469 1 4
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001060 1 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD001546 1 Reproducibility of label-free single-shot phosphoproteomics applied to CRC cell lines Homo sapiens (Human) PARTIAL 2015-04-15 cell culture -
PXD005366 51 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD001550 5 Human CRC cell line baseline phosphoproteomics Homo sapiens (Human) PARTIAL 2015-04-15 cell culture
453 453 468 1 3
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD004940 1 Performance of the Orbitrap Fusion Lumos Tribrid in single-shot analyses of human samples Homo sapiens (Human) PARTIAL 2017-03-09 HeLa cell
PXD005366 61 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD001550 2 Human CRC cell line baseline phosphoproteomics Homo sapiens (Human) PARTIAL 2015-04-15 cell culture -
455 453 460 3 13
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001060 89 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD004252 2 Modulating the selectivity of affinity absorbents to multi-phosphopeptides by a novel competitive substitution strategy Homo sapiens (Human) PARTIAL 2016-08-03 cell culture -
PXD003531 18 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD004940 6 Performance of the Orbitrap Fusion Lumos Tribrid in single-shot analyses of human samples Homo sapiens (Human) PARTIAL 2017-03-09 HeLa cell -
PXD001333 4 Anion-Exchange Chromatography of Tryptic and Phosphopeptides: WAX vs. SAX and AEX vs. ERLIC Homo sapiens (Human) PARTIAL 2015-04-23 HeLa cell -
PXD006482 12 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney
PXD002286 91 Phospo-proteomic profiling of Castration Resistant Prostate Cancer Homo sapiens (Human) PARTIAL 2016-08-19 - -
PXD005366 154 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD002394 6 Proteomic and phosphoproteomic analysis of cisplatin resistance in patient derived serous ovarian cancer Homo sapiens (Human) PARTIAL 2017-05-02 cell suspension culture -
PXD004452 60 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon -
PXD000680 3 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell -
PXD000836 5 HOPE-fixation of lung tissue allows retrospective proteome and phosphoproteome studies Homo sapiens (Human) PARTIAL 2014-05-22 lung -
PXD000612 33 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
455 453 469 3 12
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001060 45 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD000836 3 HOPE-fixation of lung tissue allows retrospective proteome and phosphoproteome studies Homo sapiens (Human) PARTIAL 2014-05-22 lung -
PXD000612 3 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD004415 11 Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells Homo sapiens (Human) COMPLETE 2017-05-11 T lymphocyte -
PXD004940 3 Performance of the Orbitrap Fusion Lumos Tribrid in single-shot analyses of human samples Homo sapiens (Human) PARTIAL 2017-03-09 HeLa cell -
PXD003531 22 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD002990 1 Complementary Phosphoproteomic Approaches Link IL-23R Downstream Signaling with Metabolic Adaptation in Lymphocytes Homo sapiens (Human) COMPLETE 2016-04-21 lymph node
PXD006482 17 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney -
PXD002394 8 Proteomic and phosphoproteomic analysis of cisplatin resistance in patient derived serous ovarian cancer Homo sapiens (Human) PARTIAL 2017-05-02 cell suspension culture -
PXD001374 11 Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling Homo sapiens (Human) PARTIAL 2015-08-24 HeLa cell -
PXD004452 23 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon -
PXD000680 3 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell -
455 453 468 3 9
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001060 35 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD000612 37 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD004415 5 Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells Homo sapiens (Human) COMPLETE 2017-05-11 T lymphocyte
PXD003531 44 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD004940 5 Performance of the Orbitrap Fusion Lumos Tribrid in single-shot analyses of human samples Homo sapiens (Human) PARTIAL 2017-03-09 HeLa cell -
PXD001333 3 Anion-Exchange Chromatography of Tryptic and Phosphopeptides: WAX vs. SAX and AEX vs. ERLIC Homo sapiens (Human) PARTIAL 2015-04-23 HeLa cell -
PXD006482 7 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney -
PXD002394 7 Proteomic and phosphoproteomic analysis of cisplatin resistance in patient derived serous ovarian cancer Homo sapiens (Human) PARTIAL 2017-05-02 cell suspension culture -
PXD004452 30 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon -
457 453 469 5 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD006482 1 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney
459 453 469 7 2
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001060 1 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD004452 1 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon
481 469 483 13 5
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001060 1 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD004415 2 Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells Homo sapiens (Human) COMPLETE 2017-05-11 T lymphocyte -
PXD003531 1 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD005366 2 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD004452 9 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon
481 470 483 12 17
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001060 86 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD004252 18 Modulating the selectivity of affinity absorbents to multi-phosphopeptides by a novel competitive substitution strategy Homo sapiens (Human) PARTIAL 2016-08-03 cell culture -
PXD000474 9 Simulated phosphopeptide spectral library for confident site localization Homo sapiens (Human) PARTIAL 2015-03-17 HeLa cell -
PXD003531 99 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD004940 32 Performance of the Orbitrap Fusion Lumos Tribrid in single-shot analyses of human samples Homo sapiens (Human) PARTIAL 2017-03-09 HeLa cell -
PXD001333 2 Anion-Exchange Chromatography of Tryptic and Phosphopeptides: WAX vs. SAX and AEX vs. ERLIC Homo sapiens (Human) PARTIAL 2015-04-23 HeLa cell -
PXD006482 16 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney -
PXD005366 775 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD002394 24 Proteomic and phosphoproteomic analysis of cisplatin resistance in patient derived serous ovarian cancer Homo sapiens (Human) PARTIAL 2017-05-02 cell suspension culture -
PXD001550 69 Human CRC cell line baseline phosphoproteomics Homo sapiens (Human) PARTIAL 2015-04-15 cell culture -
PXD004452 82 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon -
PXD001374 12 Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling Homo sapiens (Human) PARTIAL 2015-08-24 HeLa cell -
PXD000680 33 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell -
PXD000836 9 HOPE-fixation of lung tissue allows retrospective proteome and phosphoproteome studies Homo sapiens (Human) PARTIAL 2014-05-22 lung -
PXD000612 166 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD001546 25 Reproducibility of label-free single-shot phosphoproteomics applied to CRC cell lines Homo sapiens (Human) PARTIAL 2015-04-15 cell culture
PXD004415 19 Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells Homo sapiens (Human) COMPLETE 2017-05-11 T lymphocyte -
481 470 488 12 2
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD005366 46 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD004452 4 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon
481 472 488 10 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD004452 2 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon
481 472 483 10 13
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD004252 4 Modulating the selectivity of affinity absorbents to multi-phosphopeptides by a novel competitive substitution strategy Homo sapiens (Human) PARTIAL 2016-08-03 cell culture -
PXD001060 1 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD000474 1 Simulated phosphopeptide spectral library for confident site localization Homo sapiens (Human) PARTIAL 2015-03-17 HeLa cell -
PXD004940 2 Performance of the Orbitrap Fusion Lumos Tribrid in single-shot analyses of human samples Homo sapiens (Human) PARTIAL 2017-03-09 HeLa cell -
PXD003531 53 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD001333 8 Anion-Exchange Chromatography of Tryptic and Phosphopeptides: WAX vs. SAX and AEX vs. ERLIC Homo sapiens (Human) PARTIAL 2015-04-23 HeLa cell -
PXD006482 5 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney -
PXD002286 28 Phospo-proteomic profiling of Castration Resistant Prostate Cancer Homo sapiens (Human) PARTIAL 2016-08-19 - -
PXD005366 226 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture
PXD002394 8 Proteomic and phosphoproteomic analysis of cisplatin resistance in patient derived serous ovarian cancer Homo sapiens (Human) PARTIAL 2017-05-02 cell suspension culture -
PXD004452 22 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon -
PXD000680 4 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell -
PXD000612 855 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
484 470 488 15 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD005366 1 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture
579 563 592 17 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD004452 1 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon
663 663 676 1 2
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD002286 3 Phospo-proteomic profiling of Castration Resistant Prostate Cancer Homo sapiens (Human) PARTIAL 2016-08-19 -
PXD006482 1 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney -
667 663 676 5 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD004452 1 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon
682 677 691 6 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001565 9 Evaluation of phospho-tyrosine antibodies for label-free phosphoproteomics Homo sapiens (Human) PARTIAL 2015-12-09 colon,brain
682 677 703 6 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001565 7 Evaluation of phospho-tyrosine antibodies for label-free phosphoproteomics Homo sapiens (Human) PARTIAL 2015-12-09 colon,brain
839 836 848 4 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD004452 1 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon
1066 1066 1077 1 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD004452 1 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon
1073 1066 1077 8 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001565 1 Evaluation of phospho-tyrosine antibodies for label-free phosphoproteomics Homo sapiens (Human) PARTIAL 2015-12-09 colon,brain

Structures

Showing 11 results

PDB id Chain Method Resolution Stoichiometry Interfacing Molecule/Chain Complex Formation Significance Score (CSS) P-sites View Structure
5TDE A X-ray 1.7000000476837158 2 B 0.4667869 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
23 23 SER C 1.0 12.324827194213867 0.0
131 131 TYR E 0.74 43.42884063720703 0.0
263 263 SER E 1.0 23.93466567993164 15.955859184265137
489 489 SER C 0.54 52.68644714355469 0.0
577 577 SER H 1.0 42.663536071777344 0.0
579 579 TYR H 1.0 41.36654281616211 0.0
639 639 THR C 1.0 3.2942306995391846 3.1289639472961426
663 663 SER C 1.0 11.908233642578125 5.8273749351501465
667 667 SER H 1.0 1.499300241470337 0.1679818332195282
682 682 TYR E 0.85 39.003170013427734 0.0
692 692 TYR C 1.0 85.2508773803711 64.50590515136719
696 696 THR C 0.91 31.992807388305664 18.413671493530273
5TDF A X-ray 1.7999999523162842 2 B 0.48399872 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
23 23 SER C 1.0 11.60230541229248 0.0
131 131 TYR E 0.74 46.655826568603516 0.0
263 263 SER E 1.0 24.520105361938477 14.080259323120117
489 489 SER C 0.54 53.06462478637695 0.0
577 577 SER C 1.0 42.442684173583984 0.0
579 579 TYR H 1.0 40.58310317993164 0.0
639 639 THR C 1.0 2.3004279136657715 1.9661991596221924
663 663 SER C 1.0 3.460184335708618 2.755608558654785
667 667 SER H 1.0 2.3222081661224365 0.9847485423088074
682 682 TYR E 0.85 39.225074768066406 0.0
692 692 TYR C 1.0 81.52432250976562 62.66817855834961
696 696 THR C 0.91 33.46250915527344 20.423538208007812
5TDZ B X-ray 2.0 2 A 0.5819164 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
23 23 SER C 1.0 12.493255615234375 0.0
131 131 TYR E 0.74 46.63842010498047 0.0
263 263 SER E 1.0 23.443016052246094 17.45745849609375
489 489 SER C 0.54 51.39434051513672 0.0
577 577 SER H 1.0 41.82324981689453 0.0
579 579 TYR H 1.0 39.8719596862793 0.0
639 639 THR C 1.0 2.482865571975708 2.3169686794281006
663 663 SER C 1.0 5.329978942871094 3.171009063720703
667 667 SER H 1.0 2.0997469425201416 0.6152011156082153
682 682 TYR E 0.85 38.733909606933594 0.0
692 692 TYR C 1.0 82.3123550415039 62.86811828613281
696 696 THR C 0.91 29.278865814208984 19.08295249938965
3MWD B X-ray 2.0999999046325684 4 A 0.87468046 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
23 23 SER C 1.0 9.744307518005371 0.0
131 131 TYR E 0.74 51.048194885253906 0.0
263 263 SER E 1.0 31.699270248413086 0.0
489 489 SER C 0.54 38.309837341308594 0.0
577 577 SER C 1.0 30.455059051513672 0.0
579 579 TYR H 1.0 42.18972396850586 0.0
639 639 THR C 1.0 3.185469150543213 1.3413832187652588
663 663 SER C 1.0 52.58684539794922 14.753989219665527
667 667 SER H 1.0 2.379568338394165 0.3359636664390564
682 682 TYR E 0.85 36.26515579223633 0.0
692 692 TYR C 1.0 59.29745864868164 48.2217903137207
696 696 THR C 0.91 34.14081573486328 14.895881652832031
5TDM B X-ray 2.0999999046325684 2 A 0.51749665 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
23 23 SER C 1.0 14.399584770202637 0.0
131 131 TYR E 0.74 40.70554733276367 0.0
263 263 SER E 1.0 23.67072296142578 13.390336990356445
489 489 SER C 0.54 51.61765670776367 0.0
577 577 SER H 1.0 42.82000732421875 0.0
579 579 TYR H 1.0 41.57258605957031 0.16526679694652557
639 639 THR C 1.0 1.8041993379592896 1.1339917182922363
663 663 SER C 1.0 4.5864667892456055 3.2324886322021484
667 667 SER H 1.0 3.1962671279907227 1.1044390201568604
682 682 TYR E 0.85 40.1483039855957 0.0
692 692 TYR C 1.0 83.47279357910156 65.37872314453125
696 696 THR C 0.91 31.499879837036133 19.587007522583008
3MWE B X-ray 2.200000047683716 4 A 0.7390368 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
23 23 SER C 1.0 7.368875503540039 0.0
131 131 TYR E 0.74 48.700164794921875 0.0
263 263 SER E 1.0 33.634185791015625 0.0
489 489 SER C 0.54 39.015586853027344 0.0
577 577 SER C 1.0 28.53567886352539 0.0
579 579 TYR H 1.0 45.30506896972656 0.0
639 639 THR C 1.0 6.540258884429932 3.352229356765747
663 663 SER C 1.0 43.89602279663086 15.881107330322266
667 667 SER H 1.0 3.1816318035125732 0.0
682 682 TYR E 0.85 32.95628356933594 0.0
692 692 TYR C 1.0 61.01244354248047 51.44640350341797
696 696 THR C 0.91 32.429832458496094 15.877645492553711
5TET B X-ray 2.200000047683716 2 A 0.5172438 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
23 23 SER C 1.0 15.472153663635254 0.0
131 131 TYR E 0.74 43.7183837890625 0.0
263 263 SER E 1.0 25.188871383666992 19.892107009887695
489 489 SER C 0.54 52.29037857055664 0.0
577 577 SER C 1.0 41.5342903137207 0.0
579 579 TYR H 1.0 39.535682678222656 0.0
639 639 THR C 1.0 1.8208885192871094 1.6549917459487915
663 663 SER C 1.0 13.196646690368652 6.355546951293945
667 667 SER H 1.0 1.7791521549224854 0.6165708899497986
682 682 TYR E 0.85 37.497310638427734 0.0
692 692 TYR C 1.0 81.11837005615234 63.4571647644043
696 696 THR C 0.91 29.976869583129883 19.42559814453125
5TE1 A X-ray 2.25 Monomer [NA]A:903 0.047587782 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
20 20 SER C 1.0 57.55031967163086 0.0
23 23 SER C 1.0 4.312922477722168 0.0
131 131 TYR E 0.74 34.904754638671875 0.0
263 263 SER E 1.0 10.434792518615723 0.8273218274116516
489 489 SER C 0.54 48.706871032714844 0.0
577 577 SER C 1.0 34.152740478515625 0.0
579 579 TYR H 1.0 39.62326431274414 0.0
639 639 THR C 1.0 0.16833193600177765 0.0
663 663 SER C 1.0 5.949897766113281 0.0
667 667 SER H 1.0 1.237457513809204 0.0
682 682 TYR E 0.85 39.298648834228516 0.0
692 692 TYR C 1.0 9.816095352172852 0.0
696 696 THR C 0.91 18.005657196044922 0.0
5TEQ A X-ray 2.299999952316284 Monomer [NA]A:903 0.045639493 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
20 20 SER C 1.0 96.9511489868164 0.0
23 23 SER C 1.0 17.076244354248047 0.0
131 131 TYR E 0.74 34.218021392822266 0.0
263 263 SER E 1.0 9.715546607971191 1.4973046779632568
489 489 SER C 0.54 56.489715576171875 0.0
577 577 SER C 1.0 38.17889404296875 0.0
579 579 TYR H 1.0 40.86957931518555 0.0
639 639 THR C 1.0 0.16863153874874115 0.0
663 663 SER C 1.0 3.77243709564209 0.0
667 667 SER H 1.0 1.0056978464126587 0.0
682 682 TYR E 0.85 39.877132415771484 0.0
692 692 TYR C 1.0 9.994821548461914 0.0
696 696 THR C 0.91 18.854103088378906 0.0
3PFF A X-ray 2.299999952316284 2 A 0.24594301 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
23 23 SER C 1.0 11.180520057678223 0.0
131 131 TYR E 0.74 46.61432647705078 0.0
263 263 SER E 1.0 33.76553726196289 0.0
489 489 SER C 0.54 52.176170349121094 0.0
577 577 SER C 1.0 28.48240089416504 15.184100151062012
579 579 TYR H 1.0 45.785701751708984 0.0
639 639 THR C 1.0 5.033885478973389 0.0
663 663 SER C 1.0 31.237520217895508 0.0
667 667 SER H 1.0 5.697917938232422 0.0
682 682 TYR E 0.85 35.0246696472168 0.0
692 692 TYR C 1.0 9.60107135772705 0.0
696 696 THR C 0.91 15.818315505981445 0.0
5TES B X-ray 2.4000000953674316 2 A 0.45334208 131, 263, 579, 639, 663, 667, 682
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
23 23 SER C 1.0 8.540963172912598 0.0
131 131 TYR E 0.74 36.505889892578125 0.0
263 263 SER E 1.0 25.015962600708008 15.26819896697998
489 489 SER C 0.54 52.39487838745117 0.0
577 577 SER H 1.0 39.89720916748047 0.0
579 579 TYR H 1.0 44.39500427246094 0.0
639 639 THR C 1.0 2.4899401664733887 2.4899401664733887
663 663 SER C 1.0 4.813449382781982 3.024559497833252
667 667 SER H 1.0 1.1108344793319702 0.6151939630508423
682 682 TYR E 0.85 40.85185623168945 0.0
692 692 TYR C 1.0 83.0173110961914 65.28819274902344
696 696 THR C 0.91 29.00177001953125 19.581995010375977

Mutations

Showing 1 results

Swiss-Prot Position Amino acid (Wild type) Amino acid (Variant) Variant Type Disease
175 E D Polymorphism